Speeding Up the Identification of Cystic Fibrosis Transmembrane Conductance Regulator-Targeted Drugs: An Approach Based on Bioinformatics Strategies and Surface Plasmon Resonance
Cystic fibrosis (CF) is mainly caused by the deletion of Phe 508 (ΔF508) in the cystic fibrosis transmembrane conductance regulator (CFTR) protein that is thus withheld in the endoplasmic reticulum and rapidly degraded by the ubiquitin/proteasome system. New drugs able to rescue ΔF508-CFTR trafficki...
Main Authors: | Marco Rusnati, Davide Sala, Alessandro Orro, Antonella Bugatti, Gabriele Trombetti, Elena Cichero, Chiara Urbinati, Margherita Di Somma, Enrico Millo, Luis J. V. Galietta, Luciano Milanesi, Paola Fossa, Pasqualina D’Ursi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-01-01
|
Series: | Molecules |
Subjects: | |
Online Access: | http://www.mdpi.com/1420-3049/23/1/120 |
Similar Items
-
A Bittersweet Computational Journey among Glycosaminoglycans
by: Giulia Paiardi, et al.
Published: (2021-05-01) -
Virtual Drug Repositioning as a Tool to Identify Natural Small Molecules That Synergize with Lumacaftor in F508del-CFTR Binding and Rescuing
by: Paola Fossa, et al.
Published: (2022-10-01) -
Recent Strategic Advances in CFTR Drug Discovery: An Overview
by: Marco Rusnati, et al.
Published: (2020-03-01) -
A Boron Delivery Antibody (BDA) with Boronated Specific Residues: New Perspectives in Boron Neutron Capture Therapy from an In Silico Investigation
by: Alessandro Rondina, et al.
Published: (2021-11-01) -
HIV-1 Tat and Heparan Sulfate Proteoglycans Orchestrate the Setup of <i>in Cis</i> and <i>in Trans</i> Cell-Surface Interactions Functional to Lymphocyte Trans-Endothelial Migration
by: Chiara Urbinati, et al.
Published: (2021-12-01)